Adhesion plaque kinase (FAK) inhibitors inhibited the activation of CAFs and further promoted the infiltration of CD8 T cells, DC cells, and M1-type macrophages into the tumors, thus remodeling the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.